Suppr超能文献

One21:一种用于使用英科博肉毒素A治疗前额的新型可定制注射方案。

One21: A Novel, Customizable Injection Protocol for Treatment of the Forehead with IncobotulinumtoxinA.

作者信息

de Sanctis Pecora Carla

机构信息

Dermatologie-Clínica, Cirurgia, Cosmiatria e Laser, São Paulo, Brazil.

出版信息

Clin Cosmet Investig Dermatol. 2020 Feb 5;13:127-136. doi: 10.2147/CCID.S237519. eCollection 2020.

Abstract

It is well known that incobotulinumtoxinA (INCO) is an effective approved treatment for dynamic wrinkles of the upper face caused by the action of mimetic muscles over time. In doing so, it is important to maintain a balance between muscle groups and a natural facial appearance. Patients differ enormously in their facial anatomy regarding structure and function, both within and between genders, ethnicities, and age. Therefore, treating all patients with the same injection pattern and the same doses can result in undesired outcomes. There is a need for a tailored approach to achieve optimal results, as well as to increase patient satisfaction. With this in mind, the novel one21 injection technique which allows for individualized treatment has been developed for the treatment of horizontal forehead lines using INCO, resulting in a positive impact on eyebrow position and shape. This technique is the next step in a customized approach, giving natural-looking results and high patient satisfaction.

摘要

众所周知,因卡波肉毒素A(INCO)是一种经批准的有效治疗方法,用于治疗随着时间推移表情肌作用导致的上半脸动态皱纹。在此过程中,保持肌肉群之间的平衡以及自然的面部外观非常重要。患者在面部解剖结构和功能方面存在巨大差异,无论男女、种族和年龄,在群体内部和群体之间均是如此。因此,采用相同的注射方式和相同剂量治疗所有患者可能会导致不理想的结果。需要一种量身定制的方法来实现最佳效果,并提高患者满意度。考虑到这一点,已经开发出了新颖的one21注射技术,该技术允许个性化治疗,用于使用INCO治疗水平前额纹,对眉毛位置和形状产生了积极影响。这项技术是定制方法的下一步,能带来自然的效果和较高的患者满意度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9b1/7008639/3534ed62dce2/CCID-13-127-g0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验